Diversity in Mechanisms of Endothelium‐Dependent Vasodilation in Health and Disease

Small arterioles (40–150 μm) contribute to the majority of vascular resistance within organs and tissues. Under resting conditions, the basal tone of these vessels is determined by a delicate balance between vasodilator and vasoconstrictor influences. Cardiovascular homeostasis and regional tissue perfusion is largely a function of the ability of these small blood vessels to constrict or dilate in response to the changing metabolic demands of specific tissues. The endothelial cell layer of these microvessels is a key modulator of vasodilation through the synthesis and release of vasoactive substances. Beyond their vasomotor properties, these compounds importantly modulate vascular cell proliferation, inflammation, and thrombosis. Thus, the balance between local regulation of vascular tone and vascular pathophysiology can vary depending upon which factors are released from the endothelium. This review will focus on the dynamic nature of the endothelial released dilator factors depending on species, anatomic site, and presence of disease, with a focus on the human coronary microcirculation. Knowledge how endothelial signaling changes with disease may provide insights into the early stages of developing vascular inflammation and atherosclerosis, or related vascular pathologies.

[1]  Lixin Liu,et al.  Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature , 2012, Journal of Inflammation.

[2]  Rongshan Li,et al.  Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling. , 2012, American journal of physiology. Heart and circulatory physiology.

[3]  K. Pritchard,et al.  Resistance and aerobic exercise protects against acute endothelial impairment induced by a single exposure to hypertension during exertion. , 2011, Journal of applied physiology.

[4]  D. Gutterman,et al.  H2O2 Is the Transferrable Factor Mediating Flow-Induced Dilation in Human Coronary Arterioles , 2011, Circulation research.

[5]  Tian-lun Yang,et al.  Soluble epoxide hydrolase: a promising therapeutic target for cardiovascular diseases. , 2011, Die Pharmazie.

[6]  D. Gutterman,et al.  Abstract 15764: Role Of Cyclooxygenase In Flow-induced Dilation Of Human Coronary Arterioles Depends Upon Age , 2010 .

[7]  B. Hammock,et al.  Soluble Epoxide Hydrolase in Atherosclerosis , 2010, Current atherosclerosis reports.

[8]  U. Förstermann Nitric oxide and oxidative stress in vascular disease , 2010, Pflügers Archiv - European Journal of Physiology.

[9]  Michel Félétou,et al.  EDHF: an update. , 2009, Clinical science.

[10]  B. Nilius,et al.  Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. , 2008, Cardiovascular research.

[11]  J. Tune,et al.  Endogenous Adipose‐Derived Factors Diminish Coronary Endothelial Function via Inhibition of Nitric Oxide Synthase , 2008, Microcirculation.

[12]  Y. Sasaguri,et al.  Spontaneous Myocardial Infarction in Mice Lacking All Nitric Oxide Synthase Isoforms , 2008, Circulation.

[13]  Wen‐Hui Wang,et al.  Hydrogen Peroxide Stimulates the Ca2+-activated Big-Conductance K Channels (BK) Through cGMP Signaling Pathway in Cultured Human Endothelial Cells , 2008, Cellular Physiology and Biochemistry.

[14]  J. P. Brennan,et al.  Cysteine Redox Sensor in PKGIa Enables Oxidant-Induced Activation , 2007, Science.

[15]  N. Westerhof,et al.  Nitric oxide and cardiac function. , 2007, Life sciences.

[16]  S. Fitzgerald,et al.  Contributions of endothelium-derived relaxing factors to control of hindlimb blood flow in the mouse in vivo. , 2007, American journal of physiology. Heart and circulatory physiology.

[17]  R. Bryan,et al.  H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle. , 2007, American journal of physiology. Heart and circulatory physiology.

[18]  D. Gutterman,et al.  The mechanism of flow-induced dilation in human adipose arterioles involves hydrogen peroxide during CAD. , 2007, American journal of physiology. Heart and circulatory physiology.

[19]  T. Fülöp,et al.  Increased Cyclooxygenase-2 Expression and Prostaglandin-Mediated Dilation in Coronary Arterioles of Patients With Diabetes Mellitus , 2006, Circulation research.

[20]  D. Gutterman,et al.  The effect of exertional hypertension evoked by weight lifting on vascular endothelial function. , 2006, Journal of the American College of Cardiology.

[21]  H. Miura,et al.  Novel Mechanism of Vasodilation in Inflammatory Bowel Disease , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Daniel Siegl,et al.  Myoendothelial Coupling Is Not Prominent in Arterioles Within the Mouse Cremaster Microcirculation In Vivo , 2005, Circulation research.

[23]  H. Cai Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. , 2005, Cardiovascular research.

[24]  J. Tune,et al.  Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. , 2005, American journal of physiology. Heart and circulatory physiology.

[25]  F. Faraci,et al.  Vascular protection: superoxide dismutase isoforms in the vessel wall. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  I. Fleming Cytochrome P450 epoxygenases as EDHF synthase(s). , 2004, Pharmacological research.

[27]  A. Nicolosi,et al.  Mitochondrial Sources of H2O2 Generation Play a Key Role in Flow-Mediated Dilation in Human Coronary Resistance Arteries , 2003, Circulation research.

[28]  Hiroaki Shimokawa,et al.  Electron Spin Resonance Detection of Hydrogen Peroxide as an Endothelium-Derived Hyperpolarizing Factor in Porcine Coronary Microvessels , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Takashi Saito,et al.  Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles , 2003, Circulation research.

[30]  Hua Cai,et al.  Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. , 2003, Molecular pharmacology.

[31]  H. Miura,et al.  Effect of gender on endothelium-dependent dilation to bradykinin in human adipose microvessels. , 2002, American journal of physiology. Heart and circulatory physiology.

[32]  A. Koller,et al.  Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. , 2002, American journal of physiology. Heart and circulatory physiology.

[33]  J. Schrader,et al.  Contribution of cytochrome P450 metabolites to bradykinin‐induced vasodilation in endothelial NO synthase deficient mouse hearts , 2002, British journal of pharmacology.

[34]  J. Falck,et al.  Role of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factor in bovine coronary arteries. , 2001, Medical science monitor : international medical journal of experimental and clinical research.

[35]  J. Falck,et al.  EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. , 2001, American journal of physiology. Heart and circulatory physiology.

[36]  T. Giles,et al.  Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats. , 2001, American journal of hypertension.

[37]  Takashi Saito,et al.  Flow-Induced Dilation of Human Coronary Arterioles: Important Role of Ca2+-Activated K+ Channels , 2001, Circulation.

[38]  H Shimokawa,et al.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. , 2000, The Journal of clinical investigation.

[39]  L. Fuchs,et al.  BK(Ca) channels compensate for loss of NOS-dependent coronary artery relaxation in cardiomyopathy. , 2000, American journal of physiology. Heart and circulatory physiology.

[40]  N. Maeda,et al.  Vasodilator mechanisms in the coronary circulation of endothelial nitric oxide synthase-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.

[41]  D. Stepp,et al.  Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. , 2000, American journal of physiology. Heart and circulatory physiology.

[42]  L. Kuo,et al.  cAMP-independent dilation of coronary arterioles to adenosine : role of nitric oxide, G proteins, and K(ATP) channels. , 1999, Circulation research.

[43]  F. Faraci,et al.  Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[44]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[45]  B. Lévy,et al.  Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. , 1998, Circulation research.

[46]  N. Weintraub,et al.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. , 1998, Circulation research.

[47]  D. Harrison,et al.  Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[48]  S. Rajagopalan,et al.  Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. , 1997, Circulation.

[49]  M. Wahl,et al.  Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide , 1996, Peptides.

[50]  R Busse,et al.  Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. , 1996, Circulation.

[51]  S. George,et al.  Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. , 1996, Current opinion in cardiology.

[52]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[53]  D. Schuschke,et al.  Microvascular responses in the skeletal muscle of the diabetic rat. , 1996, The Journal of laboratory and clinical medicine.

[54]  M. J. Davis,et al.  Integrated regulation of pressure and flow in the coronary microcirculation. , 1996, Cardiovascular research.

[55]  L. Poston,et al.  Myogenic and flow-mediated responses in isolated mesenteric small arteries from pregnant and nonpregnant rats. , 1996, American journal of obstetrics and gynecology.

[56]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[57]  D. Lloyd‐Jones,et al.  The vascular biology of nitric oxide and its role in atherogenesis. , 1996, Annual review of medicine.

[58]  A. Ngai,et al.  Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. , 1995, Circulation research.

[59]  B. Halliwell,et al.  Nitric oxide and oxygen radicals: a question of balance , 1995, FEBS letters.

[60]  L. Kuo,et al.  Adenosine potentiates flow-induced dilation of coronary arterioles by activating KATP channels in endothelium. , 1995, The American journal of physiology.

[61]  J. Keaney,et al.  Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. , 1995, The Journal of clinical investigation.

[62]  A. Koller,et al.  Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. , 1995, Circulation research.

[63]  L. Keefer,et al.  Nitric Oxide (NO) Donor Molecules: Effect of NO Release Rate on Vascular Smooth Muscle Cell Proliferation In Vitro , 1995, Journal of cardiovascular pharmacology.

[64]  A. Banning,et al.  Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation. , 1995, Experimental nephrology.

[65]  D. Fulton,et al.  Cytochrome P450‐dependent effects of bradykinin in the rat heart , 1995, British journal of pharmacology.

[66]  R. Cohen,et al.  Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. , 1994, The American journal of physiology.

[67]  S. Papadopoulos,et al.  Endothelium dependency of contractile activity differs in infant and adult vertebral arteries. , 1994, The Journal of clinical investigation.

[68]  W. A. Bradley,et al.  Superoxide and peroxynitrite in atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Burnstock,et al.  A2‐purinoceptor‐mediated relaxation in the guinea‐pig coronary vasculature: a role for nitric oxide , 1993, British journal of pharmacology.

[70]  R. Busse,et al.  Prostacyclin and Nitric Oxide Contribute to the Vasodilator Action of Acetylcholine and Bradykinin in the Intact Rabbit Coronary Bed , 1992, Journal of cardiovascular pharmacology.

[71]  M. Ueeda,et al.  Nitric oxide modulates coronary autoregulation in the guinea pig. , 1992, Circulation research.

[72]  L. Kuo,et al.  Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. , 1992, Circulation research.

[73]  M. Lavallée,et al.  Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. , 1992, The American journal of physiology.

[74]  M. Wolin,et al.  Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate. , 1991, The American journal of physiology.

[75]  L. Kuo,et al.  Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. , 1991, The American journal of physiology.

[76]  J. Sasaki,et al.  Does superoxide underlie the pathogenesis of hypertension? , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Y. Hattori,et al.  Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. , 1991, The American journal of physiology.

[78]  A. Koller,et al.  Prostaglandins mediate arteriolar dilation to increased blood flow velocity in skeletal muscle microcirculation. , 1990, Circulation research.

[79]  E. Müller‐Schweinitzer,et al.  Characterization of the adenosine receptor in porcine coronary arteries , 1990, British journal of pharmacology.

[80]  M. Marcus,et al.  Understanding the Coronary Circulation Through Studies at the Microvascular Level , 1990, Circulation.

[81]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[82]  J. Angus,et al.  Relaxant effects of ATP and adenosine on canine large and small coronary arteries in vitro. , 1987, European journal of pharmacology.

[83]  G. Rubanyi,et al.  Endothelium‐Removal Decreases Relaxations of Canine Coronary Arteries Caused by β‐Adrenergic Agonists and Adenosine , 1985, Journal of cardiovascular pharmacology.

[84]  P. Silver,et al.  Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. , 1984, The Journal of pharmacology and experimental therapeutics.

[85]  O. Ylikorkala,et al.  Plasma prostacyclin from birth to adolescence. , 1982, Archives of disease in childhood.